INPLASY202320048

The effect of gender on the clinical outcome of PD-1/PD-L1 inhibitor in solid cancer patients

Keywords: “PD-1 inhibitor”, “PD-L1 inhibitor”, “avelumab”, “atezolizumab”, “camrelizumab”, “nivolumab”, “pembrolizumab”, “sintilimab”, “durvalumab”, “toripalimab”, “sintilimab”, “gender”, “sex”, “clinical outcomes”, “overall survival”.

Download PDF - 202320048

Review Status: completed and published